ImageneBio, Inc. (IMA) stock
IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.45−0.27 (-7.26%)
Close on Nov 12, 2026Market cap $39.16MP/E –Yield –
ImageneBio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
ImageneBio's enterprise value was -$97.16M on Nov 11, 2026, against -$35.86M a year earlier. Over the last 5 years it ranged from -$110.99M to $5.15B, with a median of $815.57M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$97.16M | – |
| 2025 | Dec 31, 2025 | -$35.86M | -104.2% |
| 2024 | Dec 31, 2024 | $848.18M | +0.3% |
| 2023 | Dec 29, 2023 | $845.74M | -14.0% |
| 2022 | Dec 30, 2022 | $983.03M | -80.9% |
| 2021 | Dec 31, 2021 | $5.15B | – |
See a number that looks wrong?